As of May 2026, there is no confirmed release date for DSM-6. The American Psychiatric Association has not announced a publication timeline for a sixth edition. What it has done — in January 2026 — is publish a formal roadmap from its Future DSM Strategic Committee proposing how the next iteration will be developed, alongside an APA spokesperson tentatively floating a publication target "about four years from now" at the APA 2025 Annual Meeting. That places the working target around 2029 — but no date has been officially confirmed. Here's what we know

If you're navigating an autism diagnosis or exploring ABA therapy services while waiting for clarity, understanding where the diagnostic framework actually stands is more useful than waiting for a sixth edition that has no official timeline.

Is DSM-6 in Development?

Yes — but with two important caveats. First, the APA is being careful not to call the work "DSM-6" yet. Second, what's being developed may not look like previous DSM editions at all.

In May 2024, the APA Board of Trustees established the Future DSM Strategic Committee, a 17-member working group chaired by Dr. Maria Oquendo, chair of psychiatry at the University of Pennsylvania Perelman School of Medicine. The committee has been working on the project since mid-2024. Four subcommittees report into it, focused on social determinants of health, quality of life and functioning, biomarkers, and structure.

The committee's first major public deliverable came on January 28, 2026, when the APA released a series of five papers in the American Journal of Psychiatry outlining its proposed roadmap. The lead paper, Initial Strategy for the Future of DSM, was authored by Oquendo and 16 other committee members and represents the most authoritative current statement on what comes after DSM-5-TR. Four accompanying commentaries cover the structure subcommittee's work, social determinants, quality of life and functioning, and biomarkers.

A key signal that this isn't a routine edition rollover: in its January 2026 press release, the APA proposed renaming the manual itself. The current "Diagnostic and Statistical Manual of Mental Disorders" would become the "Diagnostic and Scientific Manual" — a deliberate shift meant to reflect what APA CEO Marketa Wills, MD, MBA called an effort to advance "scientific rigor, cultural inclusivity, and adaptability." The committee also explicitly raised whether continuous updating should replace the traditional fixed-edition model entirely — meaning the very concept of "DSM-6" as a discrete publication may be reconsidered.

The roadmap papers were presented to the APA Board of Trustees at its March 2026 quarterly meeting for review. As of May 2026, the Board has not made a binding decision on the proposed structural changes, and no publication timeline has been formally adopted. The committee is continuing its work, including ongoing public engagement to gather feedback from clinicians, researchers, and people with lived experience of mental health diagnoses.

So yes — DSM-6 (or whatever the next iteration is ultimately called) is in active development. But the development is unusually open, the timeline is unconfirmed, and the final product may differ structurally from anything the DSM has been before.

Expected DSM-6 Release Date

There is no confirmed release date for DSM-6. Any source claiming otherwise — and several still circulate dates like "May 23, 2024" or "late 2024" — is either out of date or speculating.

The most concrete public statement on timing came at the APA 2025 Annual Meeting in Los Angeles. Speaking to Medscape Medical News, committee chair Maria Oquendo said the target publication date for the next iteration is "about four years from now." That places a tentative working target around 2029 — but Oquendo also declined to confirm whether the work would even result in something called "DSM-6," underscoring that the date should be read as directional, not committed.

Historical precedent supports a multi-year horizon. The previous editions and their gaps:

If the 2029 target holds, the gap from DSM-5-TR to DSM-6 would be the shortest between major editions in modern DSM history. That said, it's worth noting that even the DSM-5-TR took longer to produce than originally planned, and the structural ambitions of the current committee — biomarkers, dimensional frameworks, possibly a name change — are substantially more complex than a routine text revision.

There is also a real possibility that the next iteration will not arrive as a single dated release at all. The committee's January 2026 roadmap explicitly proposes moving toward a continuous-update model, in which changes are published as research warrants rather than bundled into a numbered edition. If that direction is adopted, the question "when will DSM-6 be released?" may become harder to answer because the framing of "release" itself will have changed.

The most accurate statement available as of May 2026: the APA has named a working chair, established a committee, published a roadmap, and floated a tentative 2029 target — but no firm date is on record, and the structural form of the next DSM is still being decided.

What the APA Is Actually Doing: The January 2026 Roadmap

The most important and most underreported development in the DSM-6 conversation is the APA's own published roadmap from January 2026.

The APA's Future DSM Strategic Committee — established by the APA Board of Directors in 2024 and chaired by Dr. Maria Oquendo, chair of psychiatry at the University of Pennsylvania Perelman School of Medicine — published a series of five papers in the American Journal of Psychiatry proposing a forward-looking model for how the DSM should evolve.

Key proposals in the January 2026 roadmap:

1. A possible shift from fixed editions to continuous updating. The roadmap proposes moving away from producing fixed, numbered editions released every 10–15 years toward a more dynamic, continuously updated framework that can incorporate new research as it emerges. If this direction is adopted, the very concept of "DSM-6" as a discrete, dated release may be replaced by an ongoing update system — much like how major online reference databases operate.

2. Integration of biological markers. The Biomarkers and Biological Factors Subcommittee reviewed advances in genetics, brain imaging, blood-based inflammation markers, and digital data from devices like wearables. The committee found that these markers "are beginning to reveal meaningful biological patterns that cut across traditional diagnoses" and proposed integrating biological factors into future diagnostic categories.

3. A potential name change. The roadmap proposes changing the title from Diagnostic and Statistical Manual to Diagnostic and Scientific Manual — a signal that the document aims to more strongly reflect its scientific grounding rather than its role as a statistical classification tool.

4. More culturally sensitive criteria. The framework calls for standardized assessments that account for cultural and gender factors, which influence how symptoms present and are interpreted across different populations.

These are proposals — they describe a direction the committee recommends, not decisions already implemented. But they represent the most authoritative public signal the APA has issued about the DSM's future, and they significantly complicate simple predictions about a "DSM-6 release date."

The Active APA Proposal on Autism Criteria Right Now

Here's a development that directly affects families of autistic children and is more immediately relevant than any DSM-6 speculation: the APA currently has an active proposal to clarify how autism is diagnosed under the existing DSM-5-TR.

A proposal titled "Clarification of Criterion A and Criterion B Severity Specifiers for Autism Spectrum Disorder" was approved by the DSM Steering Committee and opened for public comment with a deadline of April 30, 2026.

This is significant because the severity specifiers in ASD criteria have been a documented point of inconsistency since the DSM-5 was published in 2013. The DSM-5 introduced three severity levels (Level 1, Level 2, Level 3) based on the degree of support required — but the boundaries between these levels have been applied inconsistently across clinicians and settings. The proposed clarification aims to address this.

This matters for a specific population: autistic individuals with high IQ autism. One of the persistent clinical challenges since DSM-5 consolidated all autism subtypes into a single spectrum — removing Asperger's disorder as a separate category — is that highly intelligent autistic individuals often mask their difficulties effectively enough to score as Level 1, yet still face significant functional challenges that affect their daily lives, educational performance, and mental health. Clearer severity specifiers may help clinicians more accurately assign support levels for this group.

What this means practically: an update to ASD criteria under the current DSM-5-TR is more likely to affect diagnostic practice in the near term than the eventual arrival of DSM-6.

A Brief History of the DSM and Why the Timeline Matters

The pattern shows that new full editions typically arrive 10–15 years after the previous one. DSM-5 was published in 2013, which put a theoretical DSM-6 window between roughly 2023 and 2028 — which is why that range appears in many predictions.

However, the APA's January 2026 roadmap explicitly questions whether this edition-based model is the right approach going forward. The possibility of continuous updating rather than edition publishing represents a genuine structural shift in how the APA is thinking about the DSM's future.

The claim made by at least one ABA-related website that "DSM-6 will be released on May 23, 2024" was not accurate — that date has passed without any release, and the APA has made no such announcement at any point. No credible source has confirmed a specific release date for DSM-6.

What DSM-5-TR Says About Autism Right Now

Since DSM-6 has no confirmed release date, the DSM-5-TR — published in March 2022 — is the active diagnostic framework for autism. Understanding its current criteria is more immediately clinically relevant than any DSM-6 speculation.

The DSM-5-TR autism diagnosis requires:

Domain A — Social communication and social interaction deficits (all three of the following):

1. Deficits in social-emotional reciprocity
2. Deficits in nonverbal communicative behaviors
3. Deficits in developing, maintaining, and understanding relationships

Domain B — Restricted, repetitive patterns of behavior, interests, or activities (at least two of the following):

1. Stereotyped or repetitive motor movements, use of objects, or speech
2. Insistence on sameness, inflexible adherence to routines
3. Highly restricted, fixated interests that are abnormal in intensity or focus
4. Hyper- or hyporeactivity to sensory input

Additional criteria:

• Symptoms must be present in the early developmental period (though may not fully manifest until later)
• Symptoms cause clinically significant impairment in social, occupational, or other areas of functioning
• Not better explained by intellectual disability alone

Severity levels (the area the active APA proposal is clarifying):

• Level 1: Requiring support
• Level 2: Requiring substantial support
• Level 3: Requiring very substantial support

The DSM-5-TR added updated text on racism and discrimination's impact on diagnoses and introduced prolonged grief disorder — but the core autism criteria remained unchanged from DSM-5. The pending severity specifier clarification represents the most active area of current change for autism diagnosis.

How DSM-5 Changed Autism Diagnosis — and the Ongoing Debate

Understanding the DSM-5 autism changes from 2013 is essential context for any discussion of future revisions, because those changes still generate active clinical and research debate.

The single biggest change DSM-5 made: it eliminated the separate diagnoses of Autistic Disorder, Asperger's Disorder, Childhood Disintegrative Disorder, and Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS) — collapsing all of them into a single Autism Spectrum Disorder category.

This change had documented consequences for individuals previously diagnosed with Asperger's syndrome — historically a category associated with average or above-average intellectual ability and less overt social communication deficits. This is the population often described under the term "high IQ autism" in clinical literature. Research published in journals including Autism Research documented that some individuals who qualified for Asperger's diagnosis under DSM-IV did not meet DSM-5 ASD criteria, potentially resulting in loss of diagnosis and with it, access to services.

The argument for the consolidation was that separate categories lacked diagnostic reliability — clinicians in different settings applied the Asperger's diagnosis inconsistently, and the spectrum nature of autism was better captured by a single category with severity specifiers.

The ongoing debate is whether the severity specifiers have been sufficiently calibrated to capture individuals at Level 1 who have significant support needs — particularly those with high IQ autism who mask their difficulties effectively in clinical settings. The APA's active severity specifier proposal directly addresses this gap.

What's Likely to Change From DSM-5-TR

The January 2026 roadmap papers are the most reliable preview currently available of where the next DSM is heading. Six themes emerge from the committee's published work.

1. A four-domain diagnostic model.

The Future DSM Strategic Committee proposes organizing the next manual around four interacting domains rather than the current categorical approach: contextual factors (social determinants, environment), diagnoses themselves, biomarkers and biological factors, and transdiagnostic features (traits that cut across multiple conditions). This is a meaningful structural departure from DSM-5-TR's largely categorical framework.

2. A possible name change.

The APA's January 2026 press release proposes renaming the manual from the "Diagnostic and Statistical Manual of Mental Disorders" to the "Diagnostic and Scientific Manual." The change reflects the committee's broader emphasis on scientific evidence and global applicability.

3. A shift toward continuous updating.

Possibly the most consequential proposal in the roadmap: moving away from numbered editions released every decade or more, toward an ongoing update system. If adopted, this would mirror how major online reference databases operate and would let the manual incorporate new research as it emerges rather than wait years for the next edition.

4. Greater integration of biomarkers and biological factors.

One of the four subcommittees is specifically focused on biomarkers, reflecting the field's view that diagnosis based purely on observable symptoms — the model DSM has used since DSM-III in 1980 — will eventually need to incorporate biological signals as the underlying science develops. The committee has been candid that the field has not yet identified biomarkers reliable enough for diagnostic use, but the framework is being built so that they can be integrated when they are.

5. Cultural and global inclusivity.

The roadmap papers emphasize functioning and quality of life as core diagnostic dimensions, not separate concerns. This reflects long-standing critiques that DSM-5 too narrowly defined "disorder" without accounting for how diagnostic criteria perform across different cultural and social contexts.

6. Specific to autism — clarification of severity specifiers is happening now.

Independent of the DSM-6 timeline, the APA's DSM Steering Committee has a proposal open for public comment through April 30, 2026 titled "Clarification of Criterion A and Criterion B Severity Specifiers for Autism Spectrum Disorder." This addresses a long-documented inconsistency: since DSM-5 collapsed autism subtypes into a single spectrum in 2013, clinicians have applied the three severity levels (Level 1, Level 2, Level 3) inconsistently — particularly for autistic individuals with high IQ, who often mask effectively enough to fall into Level 1 even when their actual support needs are substantial. The clarification, if adopted, would update DSM-5-TR directly rather than waiting for DSM-6. (For more on this population, see our guide on high-IQ autism diagnosis challenges.)

What the roadmap papers do not propose is sweeping changes to the autism diagnostic criteria themselves. The DSM-5 spectrum model — Criterion A (social communication deficits), Criterion B (restricted, repetitive behaviors), and the C/D/E criteria around developmental presence and impairment — appears stable in the proposed framework. The autism-specific changes most likely to land are the severity specifier clarification (in DSM-5-TR) and gradual refinement of the existing criteria (in whatever comes next), not a fundamental restructure.

DSM-5 vs. DSM-5-TR vs. DSM-6: What's the Difference?

The three are at different stages in the DSM lifecycle, and confusing them is one of the most common mistakes in autism content online. Here's the clean breakdown.

What Changes Are Expected for Autism in Future DSM Updates

While DSM-6 itself has no confirmed timeline, several areas of autism research and clinical practice are most likely to influence whatever changes eventually arrive — based on the research landscape and the APA's stated priorities in its January 2026 roadmap.

1. Improved severity specifiers — the active proposal directly addresses this, with clarification on how Criterion A and Criterion B interact with severity level assignment. This is expected to improve consistency across clinicians and settings.

2. Gender and cultural considerations — the roadmap explicitly calls for greater cultural sensitivity in diagnostic criteria. This is directly relevant to autism: the female autism phenotype is well-documented in research but is not well-captured in current criteria, leading to documented under-identification of autistic girls and women.

3. Biological markers — the January 2026 roadmap specifically highlights genetics, brain imaging, and biomarkers as areas that future DSM updates may incorporate. For autism, where no single biological marker currently exists, this would represent a significant methodological shift in how the diagnosis is eventually defined and detected.

4. Co-occurring conditions — current DSM-5-TR criteria allow autism to be coded alongside intellectual disability, language disorders, ADHD, and anxiety — but the relationship between these conditions and autism is still imprecisely captured. Future updates may refine how co-occurring presentations are classified and coded.

What This Means for Families Navigating Autism Diagnosis Now

Families who are in the middle of an autism evaluation, recently received a diagnosis, or are trying to understand what diagnostic category applies to their child should know several things:

DSM-5-TR is the current active standard. No professional evaluating for autism today will use DSM-6 — it doesn't exist yet. Evaluations reference DSM-5-TR criteria.

The active severity specifier proposal matters. If your child's Level 1 designation feels like it doesn't reflect their actual support needs, this is a clinical conversation worth having with their diagnosing clinician — and it is the focus of the current APA proposal.

Diagnosis determines services, not just labels. Whether a child meets DSM-5-TR criteria for ASD Level 1, Level 2, or Level 3 affects what services and supports they may be eligible to receive — including ABA therapy, school-based services, and Medicaid waiver programs.

ABA therapy is not contingent on DSM-6. Whatever the APA eventually produces, the evidence base for ABA therapy — built on decades of peer-reviewed research — will continue to inform practice regardless of diagnostic framework updates. Apex ABA's programs are grounded in behavior analysis principles that support children across the full autism spectrum and at all support levels.

What Apex ABA Does While the DSM Evolves

Diagnostic criteria evolve, but the clinical need for individualized, evidence-based support doesn't wait for a new manual edition. Apex ABA's services are designed to support children based on their actual behavioral and developmental profile — not on which diagnostic category they fall into or which edition of the DSM was used for their evaluation.

Our BCBAs work with children who have received ASD diagnoses across the full severity spectrum — including children with Level 1 diagnoses who have high IQ autism and significant support needs that weren't fully captured in their initial evaluation.

As the APA's diagnostic framework continues to evolve, Apex ABA stays current on clinical developments to ensure our programming reflects the best available evidence.

If you're in North Carolina, Georgia, or Maryland and have questions about how an autism diagnosis connects to ABA therapy eligibility and services, reach out to the Apex ABA team for a free consultation — we verify insurance upfront and most families get started within 2–4 weeks.

Conclusion: Stop Waiting for DSM-6 and Focus on What's Happening Now

The honest answer to "when is DSM-6 coming out" is that no one outside the APA knows — and the APA itself has not given a date. What's more clinically relevant right now is what the APA is actually doing: proposing a continuous updating model for the DSM, clarifying ASD severity specifiers in an active proposal, and planning to integrate biological markers into future diagnostic frameworks.

For families with an autistic child, the most actionable information is what DSM-5-TR currently requires for diagnosis, how severity levels are assigned, and how a diagnosis connects to the therapy and services your child can access now.

DSM-6 will come eventually — or the diagnostic framework will evolve in a different direction entirely. What doesn't need to wait is getting the right support in place for your child.

‍

SOURCES

• https://www.psychiatry.org/news-room/news-releases/apa-releases-roadmap-for-future-of-dsm 
• https://pubmed.ncbi.nlm.nih.gov/
• https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-asd
• https://psychiatryonline.org/doi/10.1176/appi.ajp.20250877
• https://www.autismspeaks.org/autism-diagnostic-criteria-dsm-5
• https://www.apexaba.com/blog/high-iq-autism
• https://pmc.ncbi.nlm.nih.gov/articles/PMC9077590/
• https://www.webmd.com/brain/autism/mental-health-aspergers-syndrome